Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616454 | 1.00 | CTSL (0.35) | CTSLCTSBCTSKJAK2JAK1 | |
| SCHEMBL11762565 | 0.94 | CTSL (0.31) | CTSLCTSBCTSK | |
| SCHEMBL13630606 | 0.85 | CTSL (0.31) | CTSLCTSBCTSK | |
| SCHEMBL5383725 | 0.82 | — | — | |
| SCHEMBL7879739 | 0.80 | NPC1 (0.30) | — | |
| SCHEMBL1076015 | 0.80 | TSHR (0.38) | — | |
| SCHEMBL520788 | 0.80 | PTGS1 (0.32) | — | |
| SCHEMBL14256307 | 0.79 | CTSL (0.40) | CTSLCTSBCTSK | |
| SCHEMBL11790443 | 0.78 | PPM1B (0.35) | — | |
| SCHEMBL15273575 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137564-A1 | NOVEL INCLUSION COMPOUND | NIPPON SODA CO., LTD. (JP) | 2017-05-18 | — | — | US | disclosed |
| US-20160017088-A1 | NOVEL INCLUSION COMPOUND | NIPPON SODA CO., LTD. (JP) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160017088-A1 | NOVEL INCLUSION COMPOUND | SEM1, C9, EIF4A1 | CTSL 506/4885CTSB 706/4885CTSK 92/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.